.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01F_MonoclonalAntibodiesAndAntibodyDrugConjugates

Contents

Name	Description
L01FA01_Rituximab
L01FA02_Ofatumumab
L01FA03_Obinutuzumab
L01FB01_InotuzumabOzogamicin
L01FB02_MoxetumomabPasudotox
L01FC01_Daratumumab
L01FC02_Isatuximab
L01FD01_Trastuzumab
L01FD02_Pertuzumab
L01FD03_TrastuzumabEmtansine
L01FD04_TrastuzumabDeruxtecan
L01FD05_TrastuzumabDuocarmazine
L01FD06_Margetuximab
L01FE01_Cetuximab
L01FE02_Panitumumab
L01FE03_Necitumumab
L01FF01_Nivolumab
L01FF02_Pembrolizumab
L01FF03_Durvalumab
L01FF04_Avelumab
L01FF05_Atezolizumab
L01FF06_Cemiplimab
L01FF07_Dostarlimab
L01FF08_Prolgolimab
L01FF09_Tislelizumab
L01FF10_Retifanlimab
L01FF11_Sugemalimab
L01FF12_Serplulimab
L01FF13_Toripalimab
L01FG01_Bevacizumab
L01FG02_Ramucirumab
L01FX01_Edrecolomab
L01FX02_GemtuzumabOzogamicin
L01FX03_Catumaxomab
L01FX04_Ipilimumab
L01FX05_BrentuximabVedotin
L01FX06_DinutuximabBeta
L01FX07_Blinatumomab
L01FX08_Elotuzumab
L01FX09_Mogamulizumab
L01FX10_Olaratumab
L01FX11_Bermekimab
L01FX12_Tafasitamab
L01FX13_EnfortumabVedotin
L01FX14_PolatuzumabVedotin
L01FX15_BelantamabMafodotin
L01FX16_OportuzumabMonatox
L01FX17_SacituzumabGovitecan
L01FX18_Amivantamab
L01FX19_Sabatolimab
L01FX20_Tremelimumab
L01FX21_Naxitamab
L01FX22_LoncastuximabTesirine
L01FX23_TisotumabVedotin
L01FX24_Teclistamab
L01FX25_Mosunetuzumab
L01FX26_MirvetuximabSoravtansine
L01FX27_Epcoritamab
L01FX28_Glofitamab
L01FX29_Talquetamab
L01FY01_PertuzumabAndTrastuzumab
L01FY02_NivolumabAndRelatlimab
L01FY03_ProlgolimabAndNurulimab